NSI-189 is primarily investigated for its potential therapeutic effects in treating neuropsychiatric and neurodegenerative conditions. It has shown promise in preclinical studies for enhancing neurogenesis, which is the growth and development of nervous tissue. This makes it a candidate for addressing disorders such as major depressive disorder, where neurogenesis is often impaired. Additionally, it is being explored for its potential to improve cognitive function and memory, which could benefit individuals with Alzheimer's disease or other forms of dementia. Researchers are also examining its role in mitigating the effects of traumatic brain injury by promoting neuronal repair and regeneration. While still in the experimental stages, NSI-189 represents a novel approach to targeting brain health and mental well-being.